Publications:35
Behrang Mahjani, PhD
About Me
Dr. Mahjani is an Assistant Professor at the Department of Psychiatry, the Department of Artificial Intelligence and Human Health, and the Deparment of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai. His research focuses on uncovering the biological mechanisms underlying maternal and child mental health, integrating methods from statistical genetics, computational biology, and epidemiology.
The Mahjani Lab is part of the Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai. The Seaver Autism Center is a fully integrated, translational research center that leads progressive studies and provides personalized care to individuals with autism and related rare disorders. As a team, we are dedicated to discovering the biological causes of autism and developing breakthrough treatments.
Dr. Mahjani is also affiliated with the Women’s Mental Health Center and the Mindich Child Health and Development Institute at the Icahn School of Medicine at Mount Sinai.
Language
English
Position
ASSISTANT PROFESSOR | Psychiatry, ASSISTANT PROFESSOR | Genetics and Genomic Sciences, ASSISTANT PROFESSOR | Artificial Intelligence and Human Health
Research Topics
Autism, Gene Discovery, Genomics
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]
Education
BSc - Applied Mathematics, KNT University of Technology
MSc - Complex Adaptive Systems, Chalmers University of Technology
MSc - Mathematical Statistics, Chalmers University of Technology
PhD - Statistical and Scientific Computing, Uppsala University
Postdoctoral Fellowship - Epidemiology and Biostat, Karolinska Institutet
Postdoctoral Fellowship - Biological Psychiatry, Icahn School of Medicine at Mount Sinai
Awards
2025
Moderate effect size genes in autism spectrum disorder
R01 - NIMH
2023
Risk architecture of postpartum psychosis
R21 - NIMH
2020
Prenatal Maternal Depression And Anxiety, And Risk Of Neurodevelopmental Disorders In Children
Brain & Behavior Research Foundation
Research
We study the genetic and developmental mechanisms underlying childhood-onset psychiatric disorders, including autism and ADHD, as well as severe perinatal mental illnesses such as postpartum psychosis.
Publications
Selected Publications
- Postpartum Psychosis and Bipolar Disorder: Review of Neurobiology and Expert Consensus Statement on Classification. Veerle Bergink, Schahram Akbarian, Nancy Byatt, Prabha S. Chandra, Nicole Cirino, Paola Dazzan, Lot De Witte, Arianna Di Florio, Clare Dolman, Ian Jones, Astrid Kamperman, Behrang Mahjani, Samantha Meltzer-Brody, Trine Munk-Olsen, Sarah Nagle-Yang, Lauren M. Osborne, Natalie Rasgon, Thalia Robakis, Harish Thippeswamy, Simone N. Vigod, Jennifer L. Payne. Biological Psychiatry
- Deleterious coding variation associated with autism is shared across ancestries. Marina Natividad Avila, Seulgi Jung, F. Kyle Satterstrom, Jack M. Fu, Tess Levy, Laura G. Sloofman, Lambertus Klei, Thariana Pichardo, Dalia Marquez, Christine R. Stevens, Caroline M. Cusick, Jennifer L. Ames, Gabriele S. Campos, Hilda Cerros, Roberto Chaskel, Claudia I.S. Costa, Michael L. Cuccaro, Andrea del Pilar Lopez, Magdalena Fernandez, Eugenio Ferro, Liliana Galeano, Ana Cristina D.E.S. Girardi, Anthony J. Griswold, Luis C. Hernandez, Naila Lourenço, Yunin Ludena, Diana Núñez-Ríos, Rosa Oyama, Katherine P. Peña, Isaac Pessah, Rebecca Schmidt, Holly M. Sweeney, Lizbeth Tolentino, Jaqueline Y.T. Wang, Lilia Albores-Gallo, Lisa A. Croen, Carlos S. Cruz-Fuentes, Irva Hertz-Picciotto, Alexander Kolevzon, Maria Claudia Lattig, Jessica Zweifach, Catherine Sancimino, Danielle Halpern, Jennifer Foss-Feig, Sven Sandin, Abraham Reichenberg, Mafalda Barbosa, Behrang Mahjani, Silvia De Rubeis, Joseph D. Buxbaum. Nature Medicine
- Risk of Relapse in Psychotic and Bipolar Disorders After Prenatal Antipsychotic Discontinuation. Xiaoqin Liu, Shelby Smout, Behrang Mahjani, Trine Munk-Olsen, Emely Ek Blæhr, Thalia K. Robakis, Veerle Bergink. JAMA network open
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Mahjani during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Outside Employment
- Karolinska Institutet
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.